Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation study
National Natural Science Foundation of China (82130060, 82502493), China Postdoctoral Science Foundation (2025M772071), Jiangsu Provincial Basic Research ProgramNatural Science Foundation-Frontier Leading Technology Basic Research Project (BK20232008), Jiangsu Provincial Medical Innovation Center (CXZX202219), Postdoctoral Fellowship Program of CPSF (GZC20251385), and Natural Science Foundation of Jiangsu Province (BK20251687).
Authors
- Weizhu Yang (ORCID: https://orcid.org/0000-0001-8470-1709)
- Jianjian Chen (ORCID: https://orcid.org/0000-0002-4946-9446)
- Duan Xu-Hua
- Haidong Zhu (ORCID: https://orcid.org/0000-0003-4000-3081)
- Guangshao Cao
- Jinzhang Chen (ORCID: https://orcid.org/0000-0003-4964-2218)
- Yujing Xin
- Ai-Bing XU
- Haibo Shao (ORCID: https://orcid.org/0000-0002-0998-3475)
- Jun Tie (ORCID: https://orcid.org/0000-0002-8036-0393)
- Zhenyu Dai (ORCID: https://orcid.org/0000-0002-7799-1231)
- Jinwei Zhao
- Zhi-Cheng JIN
- Jiansong Ji (ORCID: https://orcid.org/0000-0003-1314-396X)
- Fanpu Ji
- Wen-Bin Ding
- Hai-Bin Shi
- Chuan-Sheng Zheng
- Ming Huang
- Qi Wang
- Rong Ding
- Ye-Ming Wu
- Lan Zhang
- Wen-Ge Xing
- Zheng-Gang Ren
- Jia-Wei Zhou
- Xiao-Li Zhu
- Yang Zhao
- Gao-Jun Teng
- Wei-Hua Zhang
- Rui-Bao Liu
- Jian-Bing Wu
- Bin-Yan Zhong
- Wei Zhao
- Kang-Shun Zhu
Institutions
- Fujian Medical University (CN)
- Union Hospital (HK)
- Ministry of Education of the People's Republic of China (CN)
- Nanchang University (CN)
- Harbin Medical University (CN)
- Nantong University (CN)
- Fudan University (CN)
- Kunming Medical University (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Lishui University (CN)
- Soochow University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Zhejiang Cancer Hospital (CN)
- Nanfang Hospital (CN)
- Nantong Tumor Hospital (CN)
- Zhongda Hospital Southeast University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Second People's Hospital of NanTong (CN)
- Shandong Provincial Hospital (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
- Zhongshan Hospital (CN)
- Yancheng Third People's Hospital (CN)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
- Henan Provincial People's Hospital (CN)
- First Hospital of China Medical University (CN)
- Zhengzhou People's Hospital (CN)
- Changzhou No.2 People's Hospital (CN)
- Jiangsu Province Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
- Chongqing Public Health Medical Center (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Xijing Hospital (CN)
- Shandong First Medical University (CN)
- Union Hospital (CN)
- Hangzhou Cancer Hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Huazhong University of Science and Technology (CN)
- Southern Medical University (CN)
- Zhejiang University (CN)
- Nanjing Medical University (CN)
- Xi'an Jiaotong University (CN)
- Chongqing Medical University (CN)
- China Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.eclinm.2026.103766
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00